Login to Your Account



Searching for the Dream Deal

'Reality Bites': Licensing Trends Highlight Less Money, More Risk

By Jennifer Boggs


Monday, May 2, 2011
With venture capital getting hard to come by and the arrival of big pharma's dreaded patent cliff, "it seems like a perfect storm" for a burst of licensing and collaboration activity for the biotech sector, said Hemmie Chang, of Foley Hoag LLP's licensing & strategic alliance practice group.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription